1.84
Rafael Holdings Inc stock is traded at $1.84, with a volume of 57,622.
It is up +1.66% in the last 24 hours and down -11.11% over the past month.
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
See More
Previous Close:
$1.81
Open:
$1.7
24h Volume:
57,622
Relative Volume:
1.71
Market Cap:
$44.53M
Revenue:
$697.00K
Net Income/Loss:
$-39.78M
P/E Ratio:
-1.1018
EPS:
-1.67
Net Cash Flow:
$-8.90M
1W Performance:
-2.13%
1M Performance:
-11.11%
6M Performance:
+5.14%
1Y Performance:
+9.52%
Rafael Holdings Inc Stock (RFL) Company Profile
Name
Rafael Holdings Inc
Sector
Industry
Phone
212-658-1450
Address
520 BROAD STREET, NEWARK
Compare RFL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RFL
Rafael Holdings Inc
|
1.84 | 44.53M | 697.00K | -39.78M | -8.90M | -1.67 |
![]()
CBRE
Cbre Group Inc
|
128.73 | 38.04B | 35.77B | 968.00M | 1.40B | 3.14 |
![]()
CSGP
Costar Group Inc
|
79.40 | 33.11B | 2.74B | 138.70M | -245.30M | 0.35 |
![]()
BEKE
Ke Holdings Inc Adr
|
22.45 | 26.81B | 10.78B | 579.98M | 881.47M | 0.493 |
![]()
JLL
Jones Lang Lasalle Inc
|
252.98 | 11.87B | 22.50B | 478.00M | 411.90M | 9.89 |
![]()
FSV
Firstservice Corp
|
170.46 | 7.75B | 4.93B | 108.16M | 203.45M | 2.40 |
Rafael Holdings Inc Stock (RFL) Latest News
Rafael Holdings Reports Q2 Fiscal 2025 Results - TipRanks
Rafael Holdings Inc Reports Q2 2025 Earnings: EPS at -$0.19, Str - GuruFocus.com
Rafael Holdings, Inc. SEC 10-Q Report - TradingView
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - br.ADVFN.com
Rafael Holdings, Inc. Reports Financial Results and Anticipates Closure of Merger with Cyclo Therapeutics in Q3 - Nasdaq
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire Inc.
Full Stock Market News from 2025-03-13 - StockTitan
San Rafael medical robotics firm revenue dips nearly 2% in 2024 - North Bay Business Journal
Cyclo Therapeutics secures $2.5 million in funding By Investing.com - Investing.com Australia
Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings - Marketscreener.com
Cyclo Therapeutics secures $2.5 million in funding - Investing.com India
Ondas appoints ex-Rafael executive to expand defense business By Investing.com - Investing.com Australia
Ondas appoints ex-Rafael executive to expand defense business - Investing.com India
Military Contracts Worth $14.4M Follow This Defense Veteran's Appointment at Ondas - StockTitan
Ekso Bionics: Q4 Earnings Snapshot - Midland Daily News
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results - Yahoo Finance
LD Micro 360 Companies: --Set to Present this Week. - ACCESS Newswire
Emerging Market ETFs: A Shield Against Trump’s Tariff Threats? - The Globe and Mail
LD Micro: 360 CompaniesSet to Present this Week - ACCESS Newswire
Kratos & RAFAEL Establish Prometheus Energetics Joint Venture, a U.S.-Based Merchant Supplier of Solid Rocket Motors - Yahoo Finance
MERGER ALERTINOV, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies - ACCESS Newswire
Head to Head Analysis: Rafael (NYSE:RFL) versus Adagene (NASDAQ:ADAG) - Defense World
Rafael Microelectronics, Inc. Approves Dividend Distribution for the Year Ended December 31, 2024, Payable on June 27, 2025 - Marketscreener.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders - The Malaysian Reserve
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc.CYTH - Marketscreener.com
Analyzing Artelo Biosciences (NASDAQ:ARTL) & Rafael (NYSE:RFL) - Defense World
Director General of the International Atomic Energy Agency (IAEA) Rafael Mariano Grossi’s visit to Fukushima Prefecture - Ministry of Foreign Affairs of Japan
Restaurant Brands International Announces Plan for Burger King® in China - Restaurant Brands International
Cyclo Therapeutics extends merger agreement with Rafael Holdings - MSN
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers of VGR, CYTH - ACCESS Newswire
Rafael Holdings Extends Merger Agreement Deadline By Investing.com - Investing.com Australia
Rafael Holdings Extends Merger Agreement Deadline - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - ACCESS Newswire
Waste Management, Inc. (NYSE:WM) SVP Rafael Carrasco Sells 4,000 Shares - Armenian Reporter
Cyclo Therapeutics reports promising NPC1 treatment findings By Investing.com - Investing.com Canada
Cyclo Therapeutics reports promising NPC1 treatment findings - Investing.com India
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC(TM) Open-Label Sub-Study in Patients ( - Marketscreener.com
Breakthrough NPC1 Treatment Data: 87% of Young Patients Show Recovery Signs in Cyclo Trial - StockTitan
Cyclo Therapeutics extends merger agreement with Rafael Holdings By Investing.com - Investing.com South Africa
Rafael Holdings Inc Stock (RFL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):